Mark Schoenebaum (@MarkSchoenebaum) profile picture

Mark Schoenebaum

@MarkSchoenebaum

Biotech/Pharma analyst since 2000 MD, Johns Hopkins School of Medicine, 2000 BA, Indiana University, 1995

 New York City
isigrp.com/main/fundamental_research_health_care.html
Joined April 2009
  • Tweets839
  • Following1.8K
  • Followers8.8K
30Media
Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)Photo by Mark Schoenebaum (@MarkSchoenebaum)
Are u going to #ASCO15 ? I'm hosting my annual mixer. So far, 77 biotech/pharma cos & 250+ investors coming. Let me know if u want to attend
13
3
1
27
Twitter poll!! Do YOU think we are in a #biotech bubble .... ?
13
8
9
This is actually the full unedited cnbc clip from yesterday--> video.cnbc.com/gallery/?vide…
2
8
3
24
Biotech guru, @MarkSchoenebaum does double-take on mega deal cnb.cx/1FQ1aEh $ALXN $GEVA
Image from CNBC Halftime Report (@HalftimeReport)
5
10
I'll be on cnbc around 12:15 pm EST today fyi
4
4
17
Mark Schoenebaum retweeted
Helen Ong (@Lin_ling_88) profile picture
Helen Ong@Lin_ling_882 May 2015
A Biotech Bottom? - Barron's (@MarkSchoenebaum comments) m.barrons.com/articles/BL-SW…

Barron's | Financial and Investment News

Barron's is a leading source of financial news, providing in-depth analysis and commentary on stocks, investments and how markets are moving across the world.

barrons.com
1
5
9
Mark Schoenebaum retweeted
Meg Tirrell (@megtirrell) profile picture
Meg Tirrell
@megtirrell1 May 2015
.@MarkSchoenebaum on @HalftimeReport next wk!
Image from Meg Tirrell (@megtirrell)
2
5
6
Mark Schoenebaum retweeted
Meg Tirrell (@megtirrell) profile picture
Meg Tirrell
@megtirrell28 Apr 2015
.@MarkSchoenebaum did you give this ISI tie to $BIIB's George Scangos?
Image from Meg Tirrell (@megtirrell)
2
2
3
Mark Schoenebaum retweeted
Meg Tirrell (@megtirrell) profile picture
Meg Tirrell
@megtirrell1 Apr 2015
Can't miss: Stelios Papadopoulos, who @MarkSchoenebaum has deemed the mayor of biotech, joins us 5p ET on @CNBCFastMoney tomorrow!
2
11
11
buy side survey on upcoming $VRTX data on Kaly+661 in del508 homozygous. What % absolute FEV1 impvmt do u expect?
Image from Mark Schoenebaum (@MarkSchoenebaum)
1
8
14
What a January in #biotech...h/t to @BioCentury:
Image from Mark Schoenebaum (@MarkSchoenebaum)
17
5
Another incredible chart from Peter Bach, et al on cancer drug pricing. Prices way up even adjusting for outcomes:
Image from Mark Schoenebaum (@MarkSchoenebaum)
1
27
20
Fresh data from the GREAT Stelios Papadopoulos shows there were way more IPOs in 2014 than in 2000:
Image from Mark Schoenebaum (@MarkSchoenebaum)
2
22
28
Riding High, Biotech Firms Remain Wary nyti.ms/1yeloU4
2
19
9
U a contrarian? Check out Wordle of investors' LEAST fav biotech & pharmas 1 year ago!! Least favs = best stocks!!
Image from Mark Schoenebaum (@MarkSchoenebaum)
5
5
8
and here's up to date information on FDA breakthrough therapy designation program:
Image from Mark Schoenebaum (@MarkSchoenebaum)
2
4
11
very cool chart from the FDA showing how drug approvals set a record in 2014:
Image from Mark Schoenebaum (@MarkSchoenebaum)
2
18
13
Despite all the noise hepatitis C demand looks pretty incredible:
Image from Mark Schoenebaum (@MarkSchoenebaum)
4
25
23
incredible chart from Peter Bach at Sloan Kettering:
Image from Mark Schoenebaum (@MarkSchoenebaum)
14
47
30
@hydrogenblimp Rationale for $3-5b, please?
Load more